Product Information
CEFTRIAXONE 1 GM VIAL is a generic product labeled by Apotex Corp., priced at $3.4500 per EA under NDC 60505614800. Its NADAC has been published 70 times since May 21, 2025.
FDA first approved this application on Jun 29, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/1
Manufacturer
Apotex Corp.NDC
60505614800
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/17/2025
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203702FDA Approved
6/29/2016
TE Code
AP
On Market Since
6/30/2017
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 1 GM VIAL has been published 70 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4500 per EA |
|---|---|
| All-time high | $3.4900 (Jun 11, 2025) |
| All-time low | $3.4500 (Sep 17, 2025) |
| 52-week high | $3.4500 |
| 52-week low | $3.4500 |
| Median price | $3.4500 |
| Average price | $3.4550 |
| Largest weekly change | -0.5% (Jun 18, 2025) |
| Weeks tracked | 70 |
| Tracking since | May 21, 2025 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-1.1%
Last surveyed Sep 16, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ceftriaxone Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 1 GM VIAL, manufactured by Apotex Corp., is $3.4500 per EA (NDC 60505614800), effective Sep 16, 2026.
How has the price of CEFTRIAXONE 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 1 GM VIAL has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 1 GM VIAL?
Since May 21, 2025, the NADAC for CEFTRIAXONE 1 GM VIAL has ranged from a low of $3.4500 (Sep 17, 2025) to a high of $3.4900 (Jun 11, 2025), with a median of $3.4500 per EA.
Are there cheaper alternatives to CEFTRIAXONE 1 GM VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFTRIAXONE 1 GM VIAL, is $1.1732 per EA — about 66% below CEFTRIAXONE 1 GM VIAL.
Who manufactures CEFTRIAXONE 1 GM VIAL?
CEFTRIAXONE 1 GM VIAL (NDC 60505614800) is labeled by Apotex Corp., and CMS classifies it as a generic product.